New York, May 15, 2026, 10:13 EDT
- POET shares dropped roughly 10% soon after the U.S. market opened, giving back some of Thursday’s gains.
- The company rolled out plans for a $400 million registered direct offering, putting up 19.05 million common shares, each paired with a matching warrant.
- Fresh capital is on the table, but so is dilution—plus investors are watching for a new CFO and any slip-ups with the latest Lumilens order.
POET Technologies shares slid after the market opened at 9:30 a.m. Friday, with traders largely shrugging off news of a fresh AI optics order and homing in on a $400 million share-and-warrant deal announced premarket. The U.S.-listed stock last changed hands at $18.47, off 10.2%, as of 10:11 a.m. EDT, Markets Insider data showed.
Why now? POET is shifting gears, aiming to ramp up from developing photonics to actually producing at scale for AI data centers. Landing a financing round of this size hands the company the cash it needs to make that jump, though it comes at the cost of dilution—current shareholders’ stakes shrink as new shares hit the market.
The company plans to sell 19,047,620 common shares bundled with warrants — which give investors the right to purchase stock later at a fixed price — directly to a single institutional investor, bypassing brokers in this registered direct offering. Each share-and-warrant unit comes in at $21, a premium to Thursday’s Nasdaq close of $20.57. The attached warrant, good for three years, is exercisable at $26.15.
POET said it intends to put the proceeds toward manufacturing infrastructure, targeted acquisitions, R&D, its light-source business, as well as operations and working capital. Also in the release, the company noted that longtime CFO Thomas Mika is planning to retire this year. The board has kicked off a search for his replacement.
Despite POET’s update—something that would normally boost a development-stage semiconductor stock—the shares faced pressure. On Thursday, POET revealed Lumilens had made an initial $50 million order for EOI, or electrical-optical interposer, engines. The company added that this Lumilens relationship might ramp up to over $500 million across five years. POET also issued Lumilens a warrant for as many as 22.9 million shares at $8.25 apiece, mostly contingent on future purchase order milestones.
POET refers to EOI as its method for combining electrical and photonic components in a single manufacturing flow, targeting faster data movement via light within AI infrastructure. “GPU interconnects remain a defining bottleneck for AI scaling,” said Lumilens CEO Ankur Singla. POET CEO Suresh Venkatesan, for his part, sees the collaboration as a way to inject “semiconductor-style manufacturing discipline” into optical engines. POET Technologies
There’s a timing wrinkle. POET flagged that actual fulfillment—and revenue—from the Lumilens order hangs on pulling off development, qualification and scaling up manufacturing. Engineering samples should land late this year; full production ramps up in step with hyperscaler rollouts in 2027.
Quarterly results didn’t offer much relief. POET posted first-quarter revenue at $503,389, with a net loss landing at $12.3 million, or 8 cents per share. Operating cash dropped by $8.8 million. Venkatesan described the Lumilens deal as an “important commercial milestone.” GlobeNewswire
It’s another blow in a turbulent stretch. Back on April 27, POET revealed every purchase order from Celestial AI had been scrapped—this after Marvell, Celestial’s new parent, pointed to supposed confidentiality violations. Even so, POET maintained it was still holding a separate purchase order worth roughly $5 million from a different tech client.
That background is relevant, with POET’s stock often moving on AI optical networking hopes—a space where heavyweights like Coherent and Lumentum compete for data-center business via optical transceivers and other gear. Coherent, for its part, pitches its datacenter lineup as advanced optical transceivers and laser solutions aimed at hyperscale networks. Lumentum, on the other hand, promotes its datacom transceivers targeting AI and cloud data centers.
The bull story hasn’t disappeared. One institutional player stepped up, taking shares above Thursday’s close—a premium deal. That infusion should help POET ease up on relying solely on early revenue, putting more weight behind manufacturing instead.
The risk here isn’t hard to see. POET’s putting out more shares ahead of Lumilens actually clearing qualification, and there’s still a chunk of warrants sitting out there—both from this financing round and the Lumilens deal—that could swell the share count if the stock moves up. Any stumble on production, revenue falling short of orders, or the CFO change rattling holders, and that dilution overhang from Friday might stick around longer than bulls hope.
Right now, investors are seeing POET’s latest capital raise as a double-edged sword—yes, it bolsters the balance sheet, but it comes at shareholders’ expense. That’s the story behind POET Technologies stock sliding today: the financing signals confidence, but it also forces existing holders to foot the bill for what’s ahead.
